pharma investing
Posted in Finance Generic Drugs PharmaWatch

Looking at Pharmaceutical Companies From An Investors View

Pharma Investing With much of the content on our site centered around the pharmaceutical industry, we thought it’d be helpful to do a post on…

Continue Reading...
ADHD Drug made by Purdue Pharma
Posted in ADHD Controversial PharmaWatch

Purdue Pharma’s ADHD Drug Approved by FDA

A subsidiary of Purdue Pharma L.P., the notorious maker of Oxycontin, recently received FDA approval to market its newest ADHD drug, Adhansia XR. The recently…

Continue Reading...
Bayer company logo
Posted in Medication PharmaWatch

When its Products Harm, Bayer Pays

When its Products Harm, Bayer Pays   When people think of companies that affect many aspects of their lives, tech giants like Apple or Google…

Continue Reading...
Vyvanse pills
Posted in Medication PharmaWatch

Vyvanse: Many Advantages as ADHD Therapy?

Vyvanse is a treatment for ADHD that is very promising. Importantly, it has several advantages that distinguish it from the many competing treatments. At Health…

Continue Reading...
Posted in New Drugs PharmaWatch

Vedolizumab – New Drug May Offer Hope To Patients Of Inflammatory Bowel Disease

Vedolizumab, a new drug, initially developed by Millennium Pharmaceuticals that was taken over by Takeda Pharmaceuticals, is a monoclonal antibody, and has been under trial…

Continue Reading...
Posted in Latest News PharmaWatch

Bayer’s Nexavar May Get FDA Approval for Thyroid Cancer

Nexavar (Sorafenib) is drug that is manufactured by Bayer and is used to treat renal cell cancer and Hepatocellular carcinoma (HCC). Depending on the individual…

Continue Reading...
Posted in General Interest New Drugs news PharmaWatch

Is making profits risking your health?

At least once per day if not more you will see on your television screen a class action lawsuit for some drug asking you to…

Continue Reading...
Pills
Posted in PharmaWatch

Lorcaserin or Lorqess: Analysis of FDA Panel

This is an analysis of Lorcaserin or Lorqess and the upcoming FDA advisory panel.  If curious or have any questions or want more such analysis,…

Continue Reading...
Bydureon injection for diabetes
Posted in PharmaWatch

Analysis: Probability of Acthar Approval

This is selected excerpts from an analysis Health and Life published for the pharmaceutical industry.  If interested in receiving similar reports for future drug approvals,…

Continue Reading...
Medicine cost
Posted in PharmaWatch

Obesity Drugs 2010, Which Is the Best?

Three weight-loss pills are going up for FDA approval this year, 2010 – Qnexa, lorcaserin, and Contrave.  Here we present the state of the field…

Continue Reading...